ID
15918
Description
Neo-Adjuvant Gemcitabine and Cisplatin in Treating Patients With Early Stage of Non Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00191763
Link
https://clinicaltrials.gov/show/NCT00191763
Keywords
Versions (2)
- 6/5/16 6/5/16 -
- 6/18/16 6/18/16 -
Uploaded on
June 18, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Carcinoma, Non-Small-Cell-Lung Cancer NCT00191763
Eligibility Carcinoma, Non-Small-Cell-Lung Cancer NCT00191763
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
any treatment within the last 30 days
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0013230
- UMLS CUI [1,2]
- C1444637
- UMLS CUI [1,3]
- C4082115
Description
concurrent tumor therapy
Data type
boolean
Alias
- UMLS CUI [1]
- C0009429
Description
pregnancy
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
Description
poorly controlled diabetes mellitus
Data type
boolean
Alias
- UMLS CUI [1]
- C0554876
Description
serious concomitant disorders
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0009488
- UMLS CUI [1,2]
- C0455684
Similar models
Eligibility Carcinoma, Non-Small-Cell-Lung Cancer NCT00191763
- StudyEvent: Eligibility
C1514463 (UMLS CUI [1,2])
C1276305 (UMLS CUI [1,2])
C1444637 (UMLS CUI [1,2])
C4082115 (UMLS CUI [1,3])
C0455684 (UMLS CUI [1,2])